TCIM
WST icon

TIAA CREF Investment Management’s West Pharmaceutical WST Stock Holding History

TIAA CREF Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$14.3M Buy
129,970
+16,827
+15% +$1.75M 0.01% 862
2018
Q4 		$11.1M Buy
113,143
+3,776
+3% +$410K 0.01% 905
2018
Q3 		$13.5M Sell
109,367
-5,222
-5% -$586K 0.01% 949
2018
Q2 		$11.4M Sell
114,589
-4,772
-4% -$439K 0.01% 1084
2018
Q1 		$10.5M Sell
119,361
-6,771
-5% -$633K 0.01% 1090
2017
Q4 		$12.4M Sell
126,132
-9,781
-7% -$959K 0.01% 1017
2017
Q3 		$13.1M Sell
135,913
-32,762
-19% -$2.96M 0.01% 989
2017
Q2 		$15.9M Buy
168,675
+22,363
+15% +$2.06M 0.01% 866
2017
Q1 		$11.9M Sell
146,312
-90,907
-38% -$7.6M 0.01% 1008
2016
Q4 		$20.1M Sell
237,219
-11,944
-5% -$939K 0.02% 748
2016
Q3 		$18.6M Buy
249,163
+10,469
+4% +$831K 0.01% 810
2016
Q2 		$18.1M Sell
238,694
-14,991
-6% -$1.09M 0.01% 766
2016
Q1 		$17.6M Sell
253,685
-37,988
-13% -$2.29M 0.01% 795
2015
Q4 		$17.6M Sell
291,673
-17,391
-6% -$1.05M 0.01% 807
2015
Q3 		$16.7M Sell
309,064
-17,672
-5% -$1.03M 0.01% 803
2015
Q2 		$19M Buy
326,736
+114
+0% +$6.36K 0.01% 805
2015
Q1 		$19.7M Sell
326,622
-2,408
-0.7% -$128K 0.01% 787
2014
Q4 		$17.5M Sell
329,030
-16,014
-5% -$801K 0.01% 827
2014
Q3 		$15.4M Sell
345,044
-9,344
-3% -$397K 0.01% 861
2014
Q2 		$14.9M Buy
354,388
+3,868
+1% +$166K 0.01% 915
2014
Q1 		$15.4M Sell
350,520
-4,650
-1% -$219K 0.01% 891
2013
Q4 		$17.4M Buy
355,170
+19,652
+6% +$920K 0.01% 850
2013
Q3 		$13.8M Buy
335,518
+3,006
+0.9% +$115K 0.01% 913
2013
Q2 		$11.7M Buy
+332,512
New +$10.9M 0.01% 954

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

TIAA CREF Investment Management's WST Position: Q1 2019 in Review

TIAA CREF Investment Management increased its West Pharmaceutical (WST) stake by 15% in Q1 2019, buying an estimated $1.75M and bringing the position to 129,970 shares worth $14.3M. The position accounts for 0.01% of the portfolio, ranked #862.

TIAA CREF Investment Management first reported a position in WST in Q2 2013 and has held it in 24 quarters since. The position peaked at $20.1M in Q4 2016. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

  • TIAA CREF Investment Management held 129,970 shares of West Pharmaceutical worth $14.3M as of Q1 2019.
  • TIAA CREF Investment Management bought 16,827 West Pharmaceutical shares in Q1 2019, an estimated $1.75M.
  • West Pharmaceutical made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #862 holding.
  • TIAA CREF Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's West Pharmaceutical position peaked at $20.1M in Q4 2016.
  • 379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.